Skip to main content
Erschienen in: Head and Neck Pathology 2/2016

14.03.2016 | Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 13, 2016, Seattle, Washington

Xeroderma Pigmentosum

verfasst von: Jennifer O. Black

Erschienen in: Head and Neck Pathology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Xeroderma pigmentosum (XP) is a rare disorder of defective UV-radiation induced damage repair that is characterized by photosensitivity with easy skin burning following minimal sun exposure, early freckling and development of lentiginous pigmentation along with other features of poikiloderma and a propensity for developing skin cancer at an early age. In this short review, the clinical, pathological, genetic and molecular aspects of XP are reviewed in the current literature. XP encompasses a spectrum of disease that overlaps with other diseases of DNA repair systems. In addition to cutaneous complications, patients are susceptible to eye conditions, neurodegenerative processes, central nervous system tumors and other tumors as a result of UV radiation exposure and its byproducts. Patients with XP frequently experience a shorter life span due to skin cancer and neurodegenerative sequelae, but aggressive preventative measures to minimize UV radiation exposure and damage can improve the course of disease and prolong life. The disease has served as a model for photoaging and UV radiation-induced cancer and has led to a better understanding of cell processes that prevent development of these disease features in normal individuals.
Literatur
1.
Zurück zum Zitat Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–50.CrossRefPubMed Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–50.CrossRefPubMed
3.
Zurück zum Zitat Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974;80:221–48.CrossRefPubMed Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974;80:221–48.CrossRefPubMed
4.
Zurück zum Zitat Kleijer WJ, Laugel V, Berneburg M. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst). 2008;7:744–50.CrossRef Kleijer WJ, Laugel V, Berneburg M. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst). 2008;7:744–50.CrossRef
5.
Zurück zum Zitat Hebra F, Kaposi M. On diseases of the skin including exanthemata, volume III. New Sydenham Soc. 1874;61:252–8. Hebra F, Kaposi M. On diseases of the skin including exanthemata, volume III. New Sydenham Soc. 1874;61:252–8.
6.
Zurück zum Zitat Neisser A. Ueber das ‘Xeroderma pigmentosum’ (Kaposi): Lioderma essentialis cum melanosi et telangiectasia. Vierteljahrschr Dermatol Syphil. 1883;47–62:0000.CrossRef Neisser A. Ueber das ‘Xeroderma pigmentosum’ (Kaposi): Lioderma essentialis cum melanosi et telangiectasia. Vierteljahrschr Dermatol Syphil. 1883;47–62:0000.CrossRef
7.
Zurück zum Zitat de Sanctis C. Cacchione: A L’idiozia xerodermica. Riv Sper Freniatr. 1932;56:269–92. de Sanctis C. Cacchione: A L’idiozia xerodermica. Riv Sper Freniatr. 1932;56:269–92.
8.
Zurück zum Zitat Per M. Xeroderma pigmentosum (Kaposi): report of a case, with special reference to clinical features and pathogenesis. Br J Dermatol. 1926;38:241–52.CrossRef Per M. Xeroderma pigmentosum (Kaposi): report of a case, with special reference to clinical features and pathogenesis. Br J Dermatol. 1926;38:241–52.CrossRef
9.
Zurück zum Zitat Gartler SM. Inborn errors of metabolism at the cell culture level. Presented at the International Medical Congress, New York, NY; 1964. Gartler SM. Inborn errors of metabolism at the cell culture level. Presented at the International Medical Congress, New York, NY; 1964.
10.
Zurück zum Zitat Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968;218:652–6.CrossRefPubMed Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968;218:652–6.CrossRefPubMed
11.
Zurück zum Zitat Setlow RB, Regan JD, German J, et al. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA. 1969;64:1035–41.CrossRefPubMedPubMedCentral Setlow RB, Regan JD, German J, et al. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA. 1969;64:1035–41.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cleaver JE, Trosko JE. Absence of excision of ultraviolet-induced cyclobutane dimers in xeroderma pigmentosum. Photochem Photobiol. 1970;11:547–50.CrossRefPubMed Cleaver JE, Trosko JE. Absence of excision of ultraviolet-induced cyclobutane dimers in xeroderma pigmentosum. Photochem Photobiol. 1970;11:547–50.CrossRefPubMed
13.
Zurück zum Zitat Reed WB, Landing B, Sugarman G, et al. Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect. JAMA. 1969;207:2073–9.CrossRefPubMed Reed WB, Landing B, Sugarman G, et al. Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect. JAMA. 1969;207:2073–9.CrossRefPubMed
14.
Zurück zum Zitat Epstein JH, Fukuyama K, Reed WB, et al. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science. 1970;168:1477–8.CrossRefPubMed Epstein JH, Fukuyama K, Reed WB, et al. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science. 1970;168:1477–8.CrossRefPubMed
15.
Zurück zum Zitat Burk PG, Lutzner MA, Clarke DD, et al. Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphocytes. J Lab Clin Med. 1971;77:759–67.PubMed Burk PG, Lutzner MA, Clarke DD, et al. Ultraviolet-stimulated thymidine incorporation in xeroderma pigmentosum lymphocytes. J Lab Clin Med. 1971;77:759–67.PubMed
16.
Zurück zum Zitat Cleaver JE. Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light. J Invest Dermatol. 1972;58:124–8.CrossRefPubMed Cleaver JE. Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light. J Invest Dermatol. 1972;58:124–8.CrossRefPubMed
17.
Zurück zum Zitat De Weerd-Kastelein EA, Keijzer W, Bootsma D. Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nat New Biol. 1972;238:80–3.CrossRefPubMed De Weerd-Kastelein EA, Keijzer W, Bootsma D. Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nat New Biol. 1972;238:80–3.CrossRefPubMed
19.
Zurück zum Zitat Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48:168–76.CrossRefPubMedPubMedCentral Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48:168–76.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Karass M, Naguib MN, Elawabdeh N, et al. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease. Fetal and Pediatr Pathol. 2015;34:120–7.CrossRef Karass M, Naguib MN, Elawabdeh N, et al. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease. Fetal and Pediatr Pathol. 2015;34:120–7.CrossRef
21.
Zurück zum Zitat Masaki T, Wang Y, DiGiovanna JJ, et al. High frequency of pTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. Pigment Cell Melanoma Res. 2014;7:454–64.CrossRef Masaki T, Wang Y, DiGiovanna JJ, et al. High frequency of pTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. Pigment Cell Melanoma Res. 2014;7:454–64.CrossRef
22.
Zurück zum Zitat Tamura D, DiGiovanna JJ, Khan SG, et al. Living with xeroderma pigmentosum: comprehensive photoreception for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 2014;30:146–52.CrossRefPubMed Tamura D, DiGiovanna JJ, Khan SG, et al. Living with xeroderma pigmentosum: comprehensive photoreception for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 2014;30:146–52.CrossRefPubMed
23.
Zurück zum Zitat Anttinen A, Koulu L, Nikoskelainen E, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008;131:1979–89.CrossRefPubMed Anttinen A, Koulu L, Nikoskelainen E, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008;131:1979–89.CrossRefPubMed
24.
Zurück zum Zitat Masutani C, Kusumoto R, Yamada A, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999;399:700–4.CrossRefPubMed Masutani C, Kusumoto R, Yamada A, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999;399:700–4.CrossRefPubMed
25.
Zurück zum Zitat Broughton BC, Cordonnier A, Kleijer WJ, et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA. 2002;99:815–20.CrossRefPubMedPubMedCentral Broughton BC, Cordonnier A, Kleijer WJ, et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA. 2002;99:815–20.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Brooks BP, Thompson AH, Bishop RJ, et al. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. Ophthalmology. 2013;120:1324–36.CrossRefPubMedPubMedCentral Brooks BP, Thompson AH, Bishop RJ, et al. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. Ophthalmology. 2013;120:1324–36.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Shabbir SH. DNA repair dysfunction and neurodegeneration: lessions from rare pediatric disorders. J Child Neurol. 2016;31:392–6.CrossRef Shabbir SH. DNA repair dysfunction and neurodegeneration: lessions from rare pediatric disorders. J Child Neurol. 2016;31:392–6.CrossRef
28.
Zurück zum Zitat Suzumura H, Arisaka O. Cerebro-oculo-facio-skeletal syndrome. Adv Exp Med Biol. 2010;685:210–4.CrossRefPubMed Suzumura H, Arisaka O. Cerebro-oculo-facio-skeletal syndrome. Adv Exp Med Biol. 2010;685:210–4.CrossRefPubMed
29.
Zurück zum Zitat Kraemer KH, DiGiovann JJ. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. Photochem Photobiol. 2015;91:452–9.CrossRefPubMedPubMedCentral Kraemer KH, DiGiovann JJ. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. Photochem Photobiol. 2015;91:452–9.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Dupuy A, Sarasin A. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease. Mutat Res. 2015;776:2–8.CrossRefPubMed Dupuy A, Sarasin A. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease. Mutat Res. 2015;776:2–8.CrossRefPubMed
Metadaten
Titel
Xeroderma Pigmentosum
verfasst von
Jennifer O. Black
Publikationsdatum
14.03.2016
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2016
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-016-0707-8

Weitere Artikel der Ausgabe 2/2016

Head and Neck Pathology 2/2016 Zur Ausgabe

Sine qua non Radiology-Pathology

Malignant Vagal Paraganglioma

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 13, 2016, Seattle, Washington

Brooke-Spiegler Syndrome and Phenotypic Variants: An Update

Neu im Fachgebiet Pathologie